CLINICAL_TRIALS
trial_result
· 2020-11-18
Clinical Trial Update: Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma [Phase 2]
Summary
Phase II trial assessing oral vinorelbine in children with recurrent or progressive unresectable low-grade glioma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centre Oscar Lambret | Conditions: Low-Grade Glioma | Phase 2 | Status: COMPLETED